Compagnie Lombard Odier SCmA’s CureVac CVAC Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,000	Closed	-$10.2K	–	460
2024 Q2	$10.2K	Sell	3,000 -3,830	-56%	-$12.5K	﹤0.01%	395
2024 Q1	$20.7K	Hold	6,830	–	–	﹤0.01%	404
2023 Q4	$28.8K	Hold	6,830	–	–	﹤0.01%	446
2023 Q3	$46.6K	Hold	6,830	–	–	﹤0.01%	432
2023 Q2	$71.2K	Hold	6,830	–	–	﹤0.01%	386
2023 Q1	$47.6K	Hold	6,830	–	–	﹤0.01%	448
2022 Q4	$41K	Hold	6,830	–	–	﹤0.01%	500
2022 Q3	$54K	Hold	6,830	–	–	﹤0.01%	457
2022 Q2	$93K	Hold	6,830	–	–	﹤0.01%	388
2022 Q1	$134K	Buy	6,830 +3,000	+78%	+$59.9K	﹤0.01%	350
2021 Q4	$131K	Buy	3,830 +2,000	+109%	+$80.5K	﹤0.01%	407
2021 Q3	$100K	Buy	1,830 +830	+83%	+$50K	﹤0.01%	431
2021 Q2	$73K	Sell	1,000 -1,475	-60%	-$147K	﹤0.01%	446
2021 Q1	$226K	Buy	+2,475	New	+$240K	0.01%	374

Other funds holding CVAC

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Compagnie Lombard Odier SCmA's CVAC Position: Q3 2024 in Review

Compagnie Lombard Odier SCmA sold out of CureVac (CVAC) in Q3 2024, closing a stake of 3,000 shares — an estimated $10.2K sold.

Compagnie Lombard Odier SCmA first reported a position in CVAC in Q1 2021 and held it in 14 quarters. The position peaked at $226K in Q1 2021. 81 funds tracked by Wall St. Rank hold CVAC as of Q3 2024.

Compagnie Lombard Odier SCmA reported no remaining CureVac position as of Q3 2024 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 3,000 CureVac shares in Q3 2024, an estimated $10.2K.
Compagnie Lombard Odier SCmA first reported a position in CureVac in Q1 2021 and held it in 14 quarters.
Compagnie Lombard Odier SCmA's CureVac position peaked at $226K in Q1 2021.
81 funds tracked by Wall St. Rank held CureVac as of Q3 2024.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q3 2024, filed 11 Oct 2024.